Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats

Journal of Diabetes and its Complications

Volumn 27, Issue 1, 2013, Pages 23-28

  Jialal, Ishwarlal ^a,b   Kaur, Harmeet ^a   Devaraj, Sridevi ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

C reactive protein; Macrophages; NF B; p47Phox; PAI 1; PKC; Tissue factor

Indexed keywords

C REACTIVE PROTEIN; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN P47; SUPEROXIDE; THROMBOPLASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; C-REACTIVE PROTEIN; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; RATS; RATS, INBRED BB;

EID: 84872489094     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.03.020     Document Type: Article

References (60)

1. S.S. Bassuk, N. Rifai, and P.M. Ridker High-sensitivity C-reactive protein: clinical importance Current Problems in Cardiology 29 2004 439 493
2. S. Bieg, G. Koike, and J. Jiang Genetic isolation of iddm 1 on chromosome 4 in the biobreeding (BB) rat Mammalian Genome 9 1998 324 326
3. R.J. Bisoendial, R.S. Birjmohun, and F. Akdim C - reactive protein elicits white blood cell activation in humans American Journal of Medicine 122 6 2009 582.e1 582.e9
4. G. Bruno, P. Fornengo, and G. Novelli C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato study Diabetes 58 2009 926 933
5. Centers for Disease Control and Prevention National Diabetes fact sheet (2005); general information and national estimates on diabetes in the United States 2005 US Dept of Health and Human Services Atlanta
6. G. Cimmino, P. Golino, and J.J. Badimon Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? Internal and Emergency Medicine 6 2011 29 34
7. H.M. Colhoun, C. Schalkwijk, M.B. Rubens, and C.D. Stehouwer C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification Diabetes Care 25 2002 1813 1817
8. M.R. Dasu, S. Devaraj, T.W. Du Clos, and I. Jialal The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells Journal of Lipid Research 48 2007 509 512
9. M.R. Dasu, S. Devaraj, and I. Jialal High glucose induces IL-1beta expression in human monocytes: mechanistic insights American Journal of Physiology. Endocrinology and Metabolism 293 2007 E337 E446
10. M.R. Dasu, R.K. Thangappan, A. Bourgette, L.A. DiPietro, R. Isseroff, and I. Jialal TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice Laboratory Investigation 90 2010 1628 1636
11. S. Devaraj, A.T. Cheung, and I. Jialal Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications Diabetes 56 2007 2790 2796
12. S. Devaraj, M.R. Dasu, U. Singh, L.V. Rao, and I. Jialal C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo Atherosclerosis 203 2009 67 74
13. S. Devaraj, M.R. Dasu, and I. Jialal Diabetes is a proinflammatory state: a translational prospective Expert Review of Endocrinology & Metabolism 5 1 2010 19 28
14. S. Devaraj, N. Glaser, S. Griffen, J. Wang-Polagruto, E. Miguelino, and I. Jialal Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes Diabetes 55 2006 774 779
15. S. Devaraj, and I. Jialal C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype Arteriosclerosis, Thrombosis, and Vascular Biology 31 2011 1397 1402
16. S. Devaraj, P.R. Kumaresan, and I. Jialal Effect of C-reactive protein on chemokine expression in human aortic endothelial cells Journal of Molecular and Cellular Cardiology 36 2004 405 410
17. S. Devaraj, U. Singh, and I. Jialal The evolving role of C-reactive protein in atherothrombosis Clinical Chemistry 55 2009 229 238
18. S. Devaraj, S.K. Venugopal, U. Singh, and I. Jialal Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and - {beta} Diabetes 54 2005 85 91
19. S. Devaraj, D.Y. Xu, and I. Jialal C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis Circulation 107 2003 398 404
20. S. Devaraj, J.M. Yun, G. Adamson, J. Galvez, and I. Jialal C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction Cardiovascular Research 84 2009 479 484
21. T.W. Du Clos, L.T. Zlock, and L. Marnell Definition of a C-reactive protein binding determinant on histones Journal of Biological Chemistry 266 1991 2167 2171
22. M. El Oudi, Z. Aouni, H. Ouertani, C. Mazigh, B. Nsiri, B. Zidi, and S. Machghoul CRP and micro-albumin: new markers of cardiovascular risk in type 2 diabetes] Annales de Cardiologie et D'angeiologie (Paris) 60 4 2011 207 210
23. R. Gill, J.A. Kemp, C. Sabin, and M.B. Pepys Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats Journal of Cerebral Blood Flow and Metabolism 24 2004 1214 1218
24. P.J. Grant Diabetes mellitus as a prothrombotic condition Journal of Internal Medicine 262 2007 157 172
25. M. Griselli, J. Herbert, and W.L. Hutchinson C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction Journal of Experimental Medicine 190 1999 1733 1740
26. H. Guan, P. Wang, R. Hui, M.L. Edin, D.C. Zeldin, and D.W. Wang Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats Clinical Chemistry 55 2009 274 284
27. T.K. Hansen, C. Forsblom, and M. Saraheimo Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes Diabetologia 53 2010 1517 1524
28. R. Hayaishi-Okano, Y. Yamasaki, and N. Katakami Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes Diabetes Care 25 2002 1432 1438
29. T.W. Hein, U. Singh, J. Vasquez-Vivar, S. Devaraj, L. Kuo, and I. Jialal Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo Atherosclerosis 206 2009 61 68
30. G.M. Hirschfield, and M.B. Pepys C-reactive protein and cardiovascular disease: new insights from an old molecule QJM: Monthly Journal of the Association of Physicians 96 2003 793 807
31. S. Kobayashi, N. Inoue, and Y. Ohashi Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein Arteriosclerosis, Thrombosis, and Vascular Biology 23 2003 1398 1404
32. H.P. Kohler, and P.J. Grant Plasminogen-activator inhibitor type 1 and coronary artery disease New England Journal of Medicine 342 2000 1792 1801
33. P. Libby, D.M. Nathan, and K. Abraham National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases: Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus Circulation 11 2005 3489 3493
34. P. Libby, and P.M. Ridker Inflammation and atherosclerosis: role of C-reactive protein in risk assessment American Journal of Medicine 116 Suppl. 6A 2004 9S 16S
35. F. Liu, H.Y. Chen, X.R. Huang, A.C. Chung, L. Zhou, P. Fu, A.J. Szalai, and H.Y. Lan C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes Diabetologia 54 10 2011 2713 2723
36. G.M. Liuzzo, L.M. Santamaria, and M. Biasucci Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein: evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation Journal of the American College of Cardiology 49 2007 185 194
37. M.L. Marcovecchio, C. Giannini, and B. Widmer C-reactive protein in relation to the development of microalbuminuria in type 1 diabetes: the Oxford Regional Prospective Study Diabetes Care 31 2008 974 976
38. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
39. J.P. Mordes, R. Bortell, E.P. Blankenhorn, A.A. Rossini, and D.L. Greiner Rat models of type 1 diabetes: genetics, environment, and autoimmunity ILAR Journal 45 2004 278 291
40. K.M. Narayan, J.P. Boyle, and T.J. Thompson Lifetime risk for diabetes mellitus in the United States Journal of the American Medical Association 290 2003 1884 1890
41. M.B. Pepys, G.M. Hirschfield, and G.A. Tennent Targeting C-reactive protein for the treatment of cardiovascular disease Nature 440 2006 1217 1221
42. A. Picardi, M.G. Valorani, and G.U. Vespasiani Raised C-reactive protein levels in patients with recent onset type 1 diabetes Diabetes/Metabolism Research and Reviews 23 2007 211 214
43. K. Prasad C-reactive protein increases oxygen radical generation by neutrophils Journal of Cardiovascular Pharmacology and Therapeutics 9 2004 203 209
44. M. Pravenec, T. Kajiya, and V. Zídek Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome Hypertension 57 2011 731 737
45. P.M. Ridker, and N. Cook Clinical usefulness of very high and very low levels of CRP across the full range of Framingham Risk Scores Circulation 109 2004 1955 1959
46. M. Romano, M. Pomilio, and S. Vigneri Endothelial perturbation in children and adolescents with type 1 diabetes: association with markers of the inflammatory reaction Diabetes Care 24 2001 1674 1678
47. C.G. Schalkwijk, D.C. Poland, and W. van Dijk Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation Diabetologia 42 1999 351 357
48. M.T. Schram, N. Chaturvedi, C.G. Schalkwijk, J.H. Fuller, C.D. Stehouwer EURODIAB Prospective Complications Study Group Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - the EURODIAB Prospective Complications Study Diabetologia 48 2005 370 378
49. M.B. Schulze, E.B. Rimm, T. Li, N. Rifai, M.J. Stampfer, and F. Hu C-reactive protein and incident cardiovascular events in diabetes Diabetes Care 27 2004 889 894
50. U. Singh, M.R. Dasu, P.G. Yancey, A. Afify, S. Devaraj, and I. Jialal Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats Journal of Lipid Research 49 2008 1015 1023
51. U. Singh, S. Devaraj, and I. Jialal C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant Arteriosclerosis, Thrombosis, and Vascular Biology 25 2005 2216 2221
52. U. Singh, S. Devaraj, J. Vasquez-Vivar, and I. Jialal C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling Journal of Molecular and Cellular Cardiology 43 2007 780 791
53. M. Soinio, J. Marnemi, M. Laakso, S. Lehto, and T. Ronnemaa High sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes Diabetes Care 29 2006 329 333
54. J. Steffel, T.F. Lüscher, and F.C. Tanner Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications Circulation 113 2006 722 731
55. J. Sundell, T. Rönnemaa, and H. Laine High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes Diabetologia 47 2004 1888 1894
56. G. Targher, L. Bertolini, G. Zoppini, L. Zenari, and G. Falezza Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy Diabetic Medicine 22 2005 999 1004
57. R. Tilley, and N. Mackman Tissue factor in hemostasis and thrombosis Seminars in Thrombosis and Hemostasis 32 2006 5 10
58. H. Trachtman, S. Futterweit, and C. Arzberger Nitric oxide and superoxide in rat mesangial cells: modulation by C-reactive protein Pediatric Nephrology 21 2006 619 626
59. S.K. Venugopal, S. Devaraj, T. Yang, and I. Jialal Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha Diabetes 51 2002 3049 3054
60. S. Verma, S. Devaraj, and I. Jialal Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis Circulation 113 2006 2135 2150